1.
Transpl Infect Dis
; 16(1): 141-4, 2014 Feb.
Article
in English
| MEDLINE
| ID: mdl-24383501
ABSTRACT
Parainfluenza infection is a cause of significant morbidity and mortality in allogeneic hematopoietic stem cell transplant (HSCT) patients. DAS181 is a novel antiviral agent with activity against influenza and parainfluenza. We report the first 2 cases, to our knowledge, of successful DAS181 use in ventilated HSCT patients with severe parainfluenza lung disease.